alpha-Glucosidase inhibition in the treatment of diabetes mellitus.
Dimitriadis
G
G
2nd Department of Internal Medicine and Propaedeutic, Athens University Medical School, Evangelismos Hospital, Greece.
Raptis
S
S
D017485:1-Deoxynojirimycin / Q000031:analogs & derivatives; D020909:Acarbose; D003920:Diabetes Mellitus / Q000188:drug therapy*; D005944:Glucosamine / Q000031:analogs & derivatives / Q000627:therapeutic use; D065089:Glycoside Hydrolase Inhibitors; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D050112:Imino Pyranoses; D012016:Reference Values; D014312:Trisaccharides / Q000627:therapeutic use
D065089:Glycoside Hydrolase Inhibitors; D007004:Hypoglycemic Agents; D050112:Imino Pyranoses; D014312:Trisaccharides; C045621:miglitol; D017485:1-Deoxynojirimycin; D005944:Glucosamine; D020909:Acarbose